OSR Health (OSRHW) Total Current Liabilities (2021 - 2026)
OSR Health (OSRHW) posted Total Current Liabilities of $17.9 million for Q1 2026, up 4.27% sequentially from $17.2 million in Q4 2025, and up 28.91% YoY from $13.9 million in Q1 2025.
OSR Health (OSRHW) Total Current Liabilities (2021 - 2026) Analysis & Trends
OSR Health has reported Total Current Liabilities for 6 years, with the latest figure at $17.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 28.91% year-over-year to $17.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.9 million (up 28.91% YoY) and the FY2025 annual result came in at $17.2 million, up 395.65% from the prior year.
- Total Current Liabilities advanced to $17.9 million in Q1 2026 per OSRHW's latest filing, from $17.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $17.9 million in Q1 2026 and troughed at $403432.0 in Q1 2023.
- A 5-year average of $7.1 million and a median of $3.4 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities jumped 580.43% in 2024, then grew 28.91% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.3 million in 2022, then jumped by 61.34% to $2.0 million in 2023, then soared by 69.91% to $3.5 million in 2024, then soared by 395.65% to $17.2 million in 2025, then rose by 4.27% to $17.9 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $17.9 million, $17.2 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 630.93 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 438.74 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 15.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.90 Mn |
| Dec 31, 2025 | 17.17 Mn |
| Sep 30, 2025 | 15.03 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 13.88 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | 3.42 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 541,371.00 |
| Mar 31, 2023 | 403,432.00 |
| Dec 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 707,207.00 |